Highlights Marinomed Biotech AG BOERSE MUENCHEN

Equities

93Z

ATMARINOMED6

Market Closed - BOERSE MUENCHEN Other stock markets 01:14:21 29/06/2024 am IST			5-day change	1st Jan Change
12.8 ^EUR	+2.81%		+1.19%	-57.48%

22/05	Transcript : Marinomed Biotech AG, Q1 2024 Earnings Call, May 22, 2024
21/05	Marinomed Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Marinomed Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024	21/05	CI
Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023	16/04	CI
Marinomed Biotech Signs Deal With DKSH to Commercialize Carragelose in Four Countries	14/12	MT
Marinomed Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	21/11	CI
Marinomed Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	17/23/17	CI
Marinomed Biotech Enters Technical Cooperation with Chinese Pharmaceutical Group	09/23/09	MT
Austria’s Marinomed Biotech Secures Mexican Market Authorization for Nasal Spray	27/23/27	MT
Marinomed Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2023	23/23/23	CI
Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2022	19/23/19	CI
Marinomed Biotech AG Reports Earnings Results for the Nine Months Ended September 30, 2022	21/22/21	CI
Marinomed Biotech AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	25/22/25	CI
Marinomed Biotech AG Confirms Financial Outlook for the Fiscal Year 2022	25/22/25	CI
Marinomed Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2022	07/22/07	CI
Marinomed Biotech AG Confirms Financial Outlook for the Fiscal Year 2022	23/22/23	CI
Marinomed Biotech AG Enters into License Agreement with Proc & Gamble on Carragelose Products	20/22/20	CI
Marinomed Biotech AG Signs New Agreement for Carragelose in South Korea	12/22/12	CI
Marinomed Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2021	12/22/12	CI
Marinomed Biotech AG and Friedrich-Alexander-Universität Erlangen-Nürnberg Publish New Data on Antiviral Efficacy of Iota-Carrageenan Against Sars-Cov-2 Variants of Concern	09/21/09	CI
Marinomed Biotech AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	22/21/22	CI
Marinomed Biotech AG Provides Earnings Guidance for the Year 2021	22/21/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Marinomed Biotech AG BOERSE MUENCHEN

Equities

93Z

ATMARINOMED6

Highlights

Filters